HomeCAPR • NASDAQ
add
Capricor Therapeutics Inc
Previous close
$31.17
Day range
$29.72 - $32.45
Year range
$4.30 - $40.37
Market cap
1.73B USD
Avg Volume
1.36M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.02M | 41.00% |
Net income | -30.17M | -323.95% |
Net profit margin | — | — |
Earnings per share | -0.62 | -287.50% |
EBITDA | -28.65M | -291.41% |
Effective tax rate | -0.01% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 318.13M | 109.96% |
Total assets | 355.95M | 108.79% |
Total liabilities | 50.16M | 100.48% |
Total equity | 305.79M | — |
Shares outstanding | 57.51M | — |
Price to book | 5.85 | — |
Return on assets | -30.22% | — |
Return on capital | -34.82% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -30.17M | -323.95% |
Cash from operations | -23.57M | -59.27% |
Cash from investing | 43.09M | 134.92% |
Cash from financing | 248.82M | 206.85% |
Net change in cash | 268.34M | 570.02% |
Free cash flow | -15.73M | -17.19% |
About
CEO
Founded
2005
Website
Employees
231
